A new study published in the Journal of Clinical Investigation found that COVID was linked to cancer regression, which could ...

Merck's Keytruda sales rose 17.2% YoY to $7.43 billion. Find out why MRK stock's strong fundamentals and high dividend yield ...

Some 10,000 patients in England are set to get their very own disease-busting jab by 2030, through the NHS Cancer Vaccine ...

In a breakthrough development, scientists from the US have found that cells activated by severe COVID-19 infection can be ...

The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO following the Director-General's ...

Barriers to widespread access to cancer treatments include excessive cost and lack of affordability, according to a review ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

See your plan by selecting location, age, and other applicable factors Sign up to be alerted when there are vaccination updates in your state: The Plan Your Vaccine page will be updated as new ...

It not only led to an incredible discovery that could lead to a treatment for breast and prostate cancers but further testing ...

COVID-19’s impact on cancer patients leads to the discovery of immune cells that may help target tumors, potentially offering ...

A recent discussion with BDO's clinical trials editor and Audrey Davis of CSC, discussed strategies to increase clinical ...

Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer ...